• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 249-263 of 415 results

1033 Exhibit: Rau, JL, ¿¿¿Determinants of Patient Adherence to an Aerosol Regimen...

Document IPR2021-00406, No. 1033-33 Exhibit - Rau, JL, ¿¿¿Determinants of Patient Adherence to an Aerosol Regimen,¿¿¿ Respiratory Care 50101346 56 2005 (P.T.A.B. Jan. 7, 2021)

cite Cite Document
Analyze

1048 Exhibit: Walmrath, D, et al, ¿¿¿Aerosolised prostacyclin in adult respiratory dist...

Document IPR2021-00406, No. 1048-46 Exhibit - Walmrath, D, et al, ¿¿¿Aerosolised prostacyclin in adult respiratory distress syndrome,¿¿¿ Lancet, 342961 62 1993 (P.T.A.B. Jan. 7, 2021)

cite Cite Document
Analyze

2109 Exhibit: EX2109 Patent Owners Demonstrative Exhibits

Document IPR2021-00406, No. 2109-239 Exhibit - EX2109 Patent Owners Demonstrative Exhibits (P.T.A.B. May. 11, 2022)

cite Cite Document
Analyze

1074 Exhibit: Orenitram¿¿ Label

Document IPR2021-00406, No. 1074-70 Exhibit - Orenitram¿¿ Label (P.T.A.B. Jan. 7, 2021)

cite Cite Document
Analyze

2001 Exhibit: EX2001 Declaration of Dr Aaron Waxman

Document IPR2021-00406, No. 2001-79 Exhibit - EX2001 Declaration of Dr Aaron Waxman (P.T.A.B. May. 17, 2021)

cite Cite Document
Analyze

2025 Exhibit: EX2025 UT v Liquidia, D Del, ECF 80

Document IPR2021-00406, No. 2025-103 Exhibit - EX2025 UT v Liquidia, D Del, ECF 80 (P.T.A.B. May. 17, 2021)

cite Cite Document
Analyze

2039 Exhibit: Ex 2039 Springer website from fn 14 of Hall Ellis Decl

Document IPR2021-00406, No. 2039-118 Exhibit - Ex 2039 Springer website from fn 14 of Hall Ellis Decl (P.T.A.B. Nov. 10, 2021)

cite Cite Document
Analyze

1044 Exhibit: 9,358,240 Patent Prosecution History excerpted

Document IPR2021-00406, No. 1044-43 Exhibit - 9,358,240 Patent Prosecution History excerpted (P.T.A.B. Jan. 7, 2021)

cite Cite Document
Analyze

2012 Exhibit: EX2012 UT v Liquidia, D Del, ECF 16

Document IPR2021-00406, No. 2012-90 Exhibit - EX2012 UT v Liquidia, D Del, ECF 16 (P.T.A.B. May. 17, 2021)

cite Cite Document
Analyze

1049 Exhibit: April 8, 2020 Press Release, ¿¿¿Liquidia Announces FDA Acceptance ...

Document IPR2021-00406, No. 1049-47 Exhibit - April 8, 2020 Press Release, ¿¿¿Liquidia Announces FDA Acceptance of New Drug Application for LIQ861 Treprostinil Inhalation Powder for the Treatment o...

cite Cite Document
Analyze

1040 Exhibit: Chew N and Chan H K, ¿¿¿Pharmaceutical Dry Powder Aerosol Deliver...

Document IPR2021-00406, No. 1040-40 Exhibit - Chew N and Chan H K, ¿¿¿Pharmaceutical Dry Powder Aerosol Delivery,¿¿¿ KONA, No 19, pp 46 56 2001 (P.T.A.B. Jan. 7, 2021)

cite Cite Document
Analyze

2060 Exhibit: Ex 2060 Waxman Inhaled Treprostinil Paper

Document IPR2021-00406, No. 2060-136 Exhibit - Ex 2060 Waxman Inhaled Treprostinil Paper (P.T.A.B. Nov. 10, 2021)

cite Cite Document
Analyze

2099 Exhibit: Ex 2099 Gonda Deposition

Document IPR2021-00406, No. 2099-228 Exhibit - Ex 2099 Gonda Deposition (P.T.A.B. Mar. 16, 2022)

cite Cite Document
Analyze

1079 Exhibit: Hill, NS, et al, ¿¿¿Inhaled Therapies for Pulmonary Hypertension,¿¿¿ Re...

Document IPR2021-00406, No. 1079-75 Exhibit - Hill, NS, et al, ¿¿¿Inhaled Therapies for Pulmonary Hypertension,¿¿¿ Respiratory Care, 606794 805 2015 (P.T.A.B. Jan. 7, 2021)

cite Cite Document
Analyze

1083 Exhibit: Declaration of Jonathan Davies ISO Motion for Pro Hac Vice Admissio...

Document IPR2021-00406, No. 1083-176 Exhibit - Declaration of Jonathan Davies ISO Motion for Pro Hac Vice Admission (P.T.A.B. Jan. 4, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 17 18 19 20 21 ... >>